postherpetic neuralgia
Conditions
Interventions
experimental group:conventional therapy plus extracorporeal shock wave therapy
control group:conventional therapy
Sponsors
Department of Pain Management, West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) patients participate and sign the informed consent form of this study voluntarily; 2) patients aged over 18, male or female, diagnosed with postherpetic neuralgia; 3) patients with VAS >= 4 points; 4) patients are able to objectively describe symptoms and actively cooperate; 5) patients who have not received extracorporeal shock wave therapy before; 6) patients did not participate in other clinical trials within 3 months before the study.
Exclusion criteria
Exclusion criteria: 1) patients who are judged by doctors to be unsuitable for the study; 2) patients are allergic to coupling agent; 3) patients with a history of tumor; 4) patients with abnormal liver and kidney function; 5) patients with abnormal coagulation function or who are using anticoagulants, or patients with thrombosis; 6) patients with cardiac pacemaker; 7) patients with infection status; 8) pregnant or puerperal patients; 9) patients with fracture or severe osteoporosis; 10) patients who cannot objectively describe their symptoms; 11) patients with any mental disorder; 12) patients who cannot be followed up on schedule.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| the quality of life score in BPI;SAS score;SDS score;PSQI score; | — |
Countries
China
Contacts
Public ContactYe Ling
Department of Pain Management, West China Hospital, Sichuan University
Outcome results
None listed